ChIP-seq experiments were also performed in murine Kmt2d-deficient lymphomas and human KMT2D-mutant lymphoma cell lines (compared to wild-type) in order to map changes in H3K4me1/2 distribution and associated changes in gene expression. The gene discussed is KMT2D; the disease is lymphoma.